tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kalpit Patel, 64 are a BUY (72.73%), 24 are a HOLD (27.27%).
Analyst Kalpit Patel, currently employed at B. RILEY, carries an average stock price target met ratio of 46.72% that have a potential upside of 51.63% achieved within 166 days.
Kalpit Patel’s has documented 175 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DERM, Journey Medical Corp at 30-Jul-2025.
Analyst best performing recommendations are on XFOR (X4 PHARMACEUTICALS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/2/2023. The price target of $16 was fulfilled within 5 days with a profit of $3.92 (32.45%) receiving and performance score of 64.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$1.63 (19.47%)
$22
1 months 25 days ago
(11-Aug-2025)
1/13 (7.69%)
$2.78 (38.50%)
174
Hold
$13
$4.63 (55.32%)
$17
1 months 25 days ago
(11-Aug-2025)
0/8 (0%)
$5.78 (80.06%)
Buy
$48
1 months 26 days ago
(10-Aug-2025)
3/8 (37.5%)
$25.45 (112.86%)
192
Hold
$14
$5.63 (67.26%)
$17
5 months 5 days ago
(01-May-2025)
1/9 (11.11%)
$4.7 (50.54%)
12
Buy
$29
$20.63 (246.48%)
$30
5 months 5 days ago
(01-May-2025)
0/21 (0%)
$19.7 (211.83%)
Which stock is Kalpit Patel is most bullish on?
Which stock is Kalpit Patel is most reserved on?
What Year was the first public recommendation made by Kalpit Patel?
